Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study.
Fiche publication
Date publication
août 2024
Journal
Journal of experimental & clinical cancer research : CR
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BEAU-FALLER Michèle, Pr FALCOZ Pierre-Emmanuel, Dr PENCREACH Erwan
Tous les auteurs :
Petracci E, Pasini L, Urbini M, Felip E, Stella F, Davoli F, Salvi M, Beau-Faller M, Tebaldi M, Azzali I, Canale M, Solli P, Lai G, Amat R, Carbonell C, Falcoz PE, Martinez-Marti A, Pencreach E, Delmonte A, Crinò L, Ulivi P
Lien Pubmed
Résumé
Factors to accurately stratify patients with early-stage non-small cell lung cancer (NSCLC) in different prognostic groups are still needed. This study aims to investigate 1) the prognostic potential of circulating cell-free (CF) and extracellular vesicles (EVs)-derived microRNA (miRNAs), and 2) their added value with respect to known prognostic factors (PFs).
Mots clés
Humans, Carcinoma, Non-Small-Cell Lung, genetics, Male, Female, Extracellular Vesicles, metabolism, Lung Neoplasms, genetics, Prognosis, Biomarkers, Tumor, Middle Aged, Aged, Prospective Studies, Neoplasm Staging, MicroRNAs, genetics, Circulating MicroRNA, Adult
Référence
J Exp Clin Cancer Res. 2024 08 22;43(1):241